netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Chapter Links...
 Details...
02.12  Expand sub section  Lipid-regulating drugs
02.12  Expand sub section  Bile acid sequestrants
Colestyramine
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

See Lipid Modification Guidance. A bile acid sequestrant may be used for particular patients groups after secondary care advice oxon.diabetes_lipidsadvice@nhs.net.

 
   
Colestipol (Colestid®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

See Lipid Modification Guidance. A bile acid sequestrant may be used for particular patients groups after secondary care advice oxon.diabetes_lipidsadvice@nhs.net.

 
   
Colesevelam (Cholestagel®)
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

Please note - due to a current manufacturing issue with colestyramine it has been agreed that clinicians can prescribe colesevelam on a temporary basis without having to seek prior approval via the OUH. Please ensure this is added to the Acute medication only to ensure it is switched back as soon as the stock issue is resolved

24th May 2019

Suitable for prescribing in primary care following recommendation from gastroenterology only (for bile acid malabsorption in patients with a true intolerance to colestyramine and colestipol). Gastroenterology will have to obtain ‘Prior Approval’ from the Medicines Optimisation team.

GPs will be notified by Medicines Optimisation team if approved for use in individual patients.

APCO September 2016.

 
Link  NICE Evidence Summary: Colesevelam for bile acid malabsorption
   
02.12  Expand sub section  Ezetimibe
02.12  Expand sub section  Fibrates
02.12  Expand sub section  Statins to top
02.12  Expand sub section  Nicotinic acid group
02.12  Expand sub section  Omega-3 fatty acid compounds
02.12  Expand sub section  PCSK9 inhibitors
02.12  Expand sub section  Other lipid modifying agents
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary